Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ensysce Biosciences (ENSC) Current Leases (2020 - 2023)

Historic Current Leases for Ensysce Biosciences (ENSC) over the last 4 years, with Q3 2023 value amounting to $2732.0.

  • Ensysce Biosciences' Current Leases fell 9228.31% to $2732.0 in Q3 2023 from the same period last year, while for Sep 2023 it was $2732.0, marking a year-over-year decrease of 9228.31%. This contributed to the annual value of $27315.0 for FY2022, which is 981.35% up from last year.
  • Per Ensysce Biosciences' latest filing, its Current Leases stood at $2732.0 for Q3 2023, which was down 9228.31% from $19120.0 recorded in Q1 2023.
  • Over the past 5 years, Ensysce Biosciences' Current Leases peaked at $35403.0 during Q3 2022, and registered a low of $2732.0 during Q3 2023.
  • Moreover, its 4-year median value for Current Leases was $21997.0 (2021), whereas its average is $20484.0.
  • Per our database at Business Quant, Ensysce Biosciences' Current Leases skyrocketed by 1179.78% in 2022 and then tumbled by 9228.31% in 2023.
  • Quarter analysis of 4 years shows Ensysce Biosciences' Current Leases stood at $25500.0 in 2020, then dropped by 2.45% to $24874.0 in 2021, then increased by 9.81% to $27315.0 in 2022, then tumbled by 90.0% to $2732.0 in 2023.
  • Its Current Leases was $2732.0 in Q3 2023, compared to $19120.0 in Q1 2023 and $27315.0 in Q4 2022.